Adaptive Biotechnologies Corp
ADPT· Nasdaq
Released Aug 2, 2023, after the close
10-Q filed Aug 2, 2023, 33 days after period end · 0000950170-23-037234
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $48.93M | $43.66M | $38.51M | $20.99M |
| Net Income | -$47.81M | -$52.05M | -$49.30M | -$33.54M |
| EPS Diluted |
Adaptive Biotechnologies Corp · CIK 1478320 · Engraved from SEC EDGAR
| -$0.33 |
| -$0.37 |
| -$0.35 |
| -$0.26 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.